Showing results (1-10 of 10) with videos related to
Sort By:
Pageof 1
Therapeutic Apheresis and Dialysis : Official Peer-Reviewed Journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy|November 4, 2014
Comparison of paricalcitol with maxacalcitol injection in Japanese hemodialysis patients with secondary hyperparathyroidismTadao Akizawa, Takashi Akiba, Hideki Hirakata, et al.CPT: Pharmacometrics & Systems Pharmacology|July 1, 2020
Population Pharmacokinetics and Exposure-Response of Luspatercept, an Erythroid Maturation Agent, in Anemic Patients With Myelodysplastic SyndromesNianhang Chen, Nastya Kassir, Abderrahmane Laadem, et al.Journal of Clinical Pharmacology|July 23, 2020
Population Pharmacokinetics and Exposure-Response Relationship of Luspatercept, an Erythroid Maturation Agent, in Anemic Patients With β-ThalassemiaNianhang Chen, Nastya Kassir, Abderrahmane Laadem, et al.Journal of Cardiac Failure|October 14, 2014
Risk factors for heart failure in patients with type 2 diabetes mellitus and stage 4 chronic kidney disease treated with bardoxolone methylMelanie P Chin, Danielle Wrolstad, George L Bakris, et al.American Journal of Nephrology|June 7, 2014
Mechanisms contributing to adverse cardiovascular events in patients with type 2 diabetes mellitus and stage 4 chronic kidney disease treated with bardoxolone methylMelanie P Chin, Scott A Reisman, George L Bakris, et al.Journal of the American Society of Nephrology : JASN|April 30, 2016
Overcoming Barriers in Kidney Health-Forging a Platform for InnovationPeter G Linde, Patrick Archdeacon, Matthew D Breyer, et al.Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|December 17, 2016
Noninvasive diagnosis of chronic kidney diseases using urinary proteome analysisJustyna Siwy, Petra Zürbig, Angel Argiles, et al.The New England Journal of Medicine|March 31, 2021
Sotatercept for the Treatment of Pulmonary Arterial HypertensionMarc Humbert, Vallerie McLaughlin, J Simon R Gibbs, et al.The New England Journal of Medicine|March 27, 2020
A Phase 3 Trial of Luspatercept in Patients with Transfusion-Dependent β-ThalassemiaM Domenica Cappellini, Vip Viprakasit, Ali T Taher, et al.The New England Journal of Medicine|January 9, 2020
Luspatercept in Patients with Lower-Risk Myelodysplastic SyndromesPierre Fenaux, Uwe Platzbecker, Ghulam J Mufti, et al.Pageof 1